Skip to main content
. Author manuscript; available in PMC: 2020 Jul 6.
Published in final edited form as: Nat Med. 2020 Jan 6;26(1):59–64. doi: 10.1038/s41591-019-0709-7

Fig. 1: Intestinal fungal burden in allo-HCT patients.

Fig. 1:

a,b, Quantitative fungal cultures of fecal samples from (a) candidemic and (b) non-candidemic patients at indicated time points during allo-HCT. c, Quantitative fungal 18S rDNA levels in candidemic (red, n = 55) and non-candidemic (green, n = 99) patient groups during allo-HCT. The solid line represents the dynamic trend using moving average filtering, with the shaded area indicating the 95% confidence intervals. Each dot represents an individual sample (a-c) and each color a unique patient (a, b). The grey shade in panels (a) and (c) indicate the time range of first positive fungal blood cultures. N.D.: not detected.